From 10th Feb RNS - Read as you will ....5 Mar 2026 08:45
- I think 3 weeks is enough time based on below so we could hear about Tech transfer, injection, CDX or CBR or even estonia next week. Strap on as we nearly there ....
"In parallel, management has undertaken a concerted effort to significantly reduce the Company's burn rate. As part of this initiative, the Company
outsourced the manufacturing of HG-CT-1 to a specialised external manufacturer, Made Scientific ("MADE"). The Company devoted substantial time
to the technology transfer process and is currently in the final stages of this work, in preparation for the manufacture of HG-CT-1 for the first adult
and pediatric patients. The next group of adult patients will be treated with an increased dose while pediatric patients will receive the lowest dose of
HG-CT-1 which is going to be the same as in the first group of adults.
While the Company's efforts remain primarily focused on the HG-CT-1 clinical trials, it continues to advance its CDX and CBR product candidates where
possible and expects to report further progress on these programmes in due course."